22 May 2013
Keywords: hana, initiates, ph, ii, marqibo, aml, study
Article | 13 August 2007
Canadian biopharmaceutical firm Tekmira Pharmaceuticals says that USA-based partner Hana Biosciences has initiated a Phase II clinical
trial of Marqibo ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 August 2007
© 2013 thepharmaletter.com